Successful treatment of solar urticaria with <scp>UVA</scp>1 hardening in three patients

Lyons, Alexis B.; Peacock, Anjelica; Zubair, Raheel; Hamzavi, Iltefat; Lim, Henry W.

doi:10.1111/phpp.12447

Cited by 14 publications

(4 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Солнечная крапивница характеризуется рецидивирующими эпизодами уртикарных высыпаний на участках кожи, подверженных воздействию солнечного света. Несмотря на то, что жизнеугрожающие реакции при данном типе ХИНДК встречаются крайне редко, заболевание может значительно ограничивать повседневную активность пациентов и снижать качество жизни [102][103][104][105].…”

Section: солнечная крапивницаunclassified

Chronic-induced urticaria; classification, actual aspects of diagnosis and therapy

Serdotetskova

Danilycheva

Fomina

et al. 2023

Russian Journal of Allergy

View full text Add to dashboard Cite

Chronic induced urticaria (CIndU) is a group of diseases characterized by the occurrence of itchy wheals and/or angioedema in response to specific triggers, such as mechanical irritation, exposure of high and low temperatures, vibration, as well as ultraviolet radiation of various spectrum, appearing for 6 or more weeks. This group of diseases is characterized by a long duration, a significant impact to the patients quality of life, as well as the risk of severe life-threatening reactions. Diagnosis of induced urticaria - patient-safe reproduction of symptoms by exposure to a trigger (temperature, mechanical, etc.). Currently, there are no registered medical devices in the Russian Federation for the threshold diagnosis of most physical forms of urticaria, which makes it difficult to diagnose and dynamically monitor the state of these groups of patients and the response to treatment. The question of therapy with CIndU also remains open, due to the insufficient effectiveness of the recommended and available methods of therapy. This article provides an rewiew of current literature data.

show abstract

Section: солнечная крапивницаunclassified

Chronic-induced urticaria; classification, actual aspects of diagnosis and therapy

Serdotetskova

Danilycheva

Fomina

et al. 2023

Russian Journal of Allergy

View full text Add to dashboard Cite

show abstract

“…Although not life-threatening, it can significantly impair the quality of life. [22][23][24][25] After prolonged exposure to the sun, there may localize angioedema and severe cases may have other systemic symptoms such as weakness, headache, or nausea. It is also a rare type of chronic urticaria affecting <0.5% of cases of CIndU.…”

Section: Solar Urticariamentioning

confidence: 99%

Chronic inducible urticaria: Clinical presentation, diagnosis, and management

Can

Fomina

Kocatürk

2022

IJSA

View full text Add to dashboard Cite

Chronic inducible urticaria (CIndU) is a subtype of chronic urticaria characterized by recurrent itchy wheals and/or angioedema for more than 6 weeks. CIndU has a longer disease duration than chronic spontaneous urticaria (CSU) and wheals are shorter lasting than CSU. CIndU incudes physical and non-physical urticaria. Triggers and diagnosis of subtypes of CIndU differ from each other. Patient education for avoiding triggers is an important aspect of the treatment of CIndU. There is no significant difference in the treatment approach for CIndU and CSU. In this article, we have discussed different types of CIndU, their clinical features, diagnosis, and management.

show abstract

“…19 NB-UVB and UVA1 are also useful for therapeutic hardening of patients with polymorphous light eruption and solar urticaria, respectively. 20 For treatment-resistant dermatitis of the hands and feet, topical PUVA is frequently used. Oral PUVA is helpful for plaque stage mycosis fungoides, other forms of cutaneous lymphoma, and as a second-line UV-based treatment option for recalcitrant skin conditions that have failed or responded inadequately to NB-UVB.…”

Section: Efficacy Datamentioning

confidence: 99%

Role of phototherapy in the era of biologics

Torres

Lyons

Hamzavi

et al. 2021

Journal of the American Academy of Dermatology

Self Cite

View full text Add to dashboard Cite

Phototherapy is a safe and effective treatment for many dermatologic conditions. With the advent of novel biologics and small molecule inhibitors, it is important to critically evaluate the role of phototherapy in dermatology. Surveys have shown that many dermatology residency programs do not dedicate time to teaching residents how to prescribe or administer phototherapy. Limitations of phototherapy include access to a center, time required for treatments, and insurance approval. Home phototherapy, a viable option, is also underused. However, it should be emphasized that modern phototherapy has been in use for over 40 years, has an excellent safety profile, and does not require laboratory monitoring. It can be safely combined with many other treatment modalities, including biologics and small molecule inhibitors. In addition, phototherapy costs significantly less than these novel agents. Dermatologists are the only group of physicians who have the expertise and proper training to deliver this treatment modality to our patients. Therefore, to continue to deliver high-quality, cost-effective care, it is imperative that phototherapy be maintained as an integral part of the dermatology treatment armamentarium. ( J Am Acad Dermatol 2021;84:479-85.)

show abstract

Successful treatment of solar urticaria with UVA1 hardening in three patients

Cited by 14 publications

References 14 publications

Chronic-induced urticaria; classification, actual aspects of diagnosis and therapy

Chronic-induced urticaria; classification, actual aspects of diagnosis and therapy

Chronic inducible urticaria: Clinical presentation, diagnosis, and management

Role of phototherapy in the era of biologics

Contact Info

Product

Resources

About